Status and phase
Conditions
Treatments
About
The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.
Full description
This is phase 2, randomized, double-blind, placebo-controlled, multicenter study to assess the safety and efficacy of LB-P8 in adult patients with primary sclerosing cholangitis(PSC).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
87 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
LISCure Biosciences Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal